Back to state act
Description
On 21 April 2020, the Norwegian Medicines Agency introduced a notification requirement on exports of pharmaceutical drugs to treat obstructive pulmonary disease following the COVID-19 outbreak. The Ag...
Sign in to see full description
Intervention Details
Intervention Type
Export licensing requirement
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
21 Apr 2020
Revocation date
31 Dec 2020
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 3 products
Threads
See all
This intervention is not part of any Thread yet.